Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Terazosin monohydrochloride dihydrate

Terazosin monohydrochloride dihydrate

pharmaceutical raw materials
Terazosin monohydrochloride dihydrate structure

Terazosin monohydrochloride dihydrate 

structure
  • CAS No:

    70024-40-7

  • Formula:

    C19H25N5O4.ClH.2H2O

  • Chemical Name:

    Terazosin monohydrochloride dihydrate

  • Synonyms:

    Methanone,[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-,hydrochloride,hydrate (1:1:2);Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-,monohydrochloride,dihydrate;Terazosin monohydrochloride dihydrate;Terazosin hydrochloride dihydrate

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Terazosin Hydrochloride dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH).Target: Alpha-1 Adrenergic ReceptorTerazosin Hydrochloride dihydrate is an a1-selective blocker. Its inhibitory effect on prostate tumor growth may be the result of antiangiogenic activity. Terazosin Hydrochloride dihydrate is an inhibitor of α1A-AR, α1B-AR, α1D-AR and α2B-AR [1].

Terazosin monohydrochloride dihydrate Basic Attributes

459.92

459.188446

1533716-785-6

2934990002

Characteristics

105

271-274 °C

LD50 in male, female rats (mg/kg): 277, 293 i.v. (Fort)

Safety Information

NONH for all modes of transport

22

TK8046000

Xn

P301 + P312 + P330

H302

|Warning|H302 (64.79%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501|Aggregated GHS information provided by 142 companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION. (See all compounds classified as Urological Agents.)|Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)

A 45975

Terazosin monohydrochloride dihydrate Use and Manufacturing

Uses

analgesic, antiinflammatory

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:459.9
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:4
Exact Mass:459.1884614
Monoisotopic Mass:459.1884614
Topological Polar Surface Area:105
Heavy Atom Count:31
Complexity:544
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:4
Compound Is Canonicalized:Yes

Recommended Suppliers of Terazosin monohydrochloride dihydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.